Expression of α-synuclein, the precursor of non-amyloid β component of Alzheimer's disease amyloid, in human cerebral blood vessels

被引:56
|
作者
Tamo, W
Imaizumi, T [1 ]
Tanji, K
Yoshida, H
Mori, F
Yoshimoto, M
Takahashi, H
Fukuda, I
Wakabayashi, K
Satoh, K
机构
[1] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Vasc Biol, Hirosaki, Aomori 0368562, Japan
[2] Hirosaki Univ, Sch Med, Inst Brain Sci, Dept Mol Biol, Hirosaki, Aomori 0368562, Japan
[3] Taisho Pharmaceut Co Ltd, Med Res Labs, Mol Biol Lab, Omiya, Saitama 3308530, Japan
[4] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata 9518585, Japan
[5] Hirosaki Univ, Sch Med, Dept Surg 1, Hirosaki, Aomori 0368562, Japan
基金
日本学术振兴会;
关键词
alpha-synuclein; endothelial cells; smooth muscle cells; amyloid beta; non-amyloid beta component; precursor of non-amyloid beta component; Parkinson's disease; Alzheimer's disease;
D O I
10.1016/S0304-3940(02)00297-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The non-amyloid beta component of Alzheimer's disease amyloid (NAC) is detected in cerebral amyloid angiopathy; and the precursor of NAC is now known to be identical to alpha-synuclein (alpha-S), a major component of Lewy bodies in Parkinson's disease. We studied if cerebral vascular cells express alpha-S. Immunohistochemical studies of human cerebral tissues from control and cerebral amyloid angiopathy patients revealed the expression of alpha-S in vascular endothelial and smooth muscle cells. Then we studied the expression of alpha-S in vitro using cultures of vascular cells. Cultures of human umbilical vein endothelial cells and umbilical artery smooth muscle cells were found to constitutively express alpha-S messenger RNA and protein. alpha-S is normally expressed in vascular cells and may play some physiological role in the vascular wall. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 8
页数:4
相关论文
共 50 条
  • [31] Amyloid precursor protein mRNAs in Alzheimer's disease
    Harrison, PJ
    WightonBenn, WH
    Heffernan, JM
    Sanders, MW
    Pearson, RCA
    NEURODEGENERATION, 1996, 5 (04): : 409 - 415
  • [32] Amyloid Precursor Protein Processing in Alzheimer's Disease
    Bhadbhade, Adwait
    Cheng, Davis Weizhong
    IRANIAN JOURNAL OF CHILD NEUROLOGY, 2012, 6 (01) : 1 - 4
  • [33] Genetics of β-Amyloid Precursor Protein in Alzheimer's Disease
    Julia, T. C. W.
    Goate, Alison M.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (06):
  • [34] Amyloid precursor protein, copper and Alzheimer's disease
    Multhaup, G
    BIOMEDICINE & PHARMACOTHERAPY, 1997, 51 (03) : 105 - 111
  • [35] The amyloid precursor protein of Alzheimer's disease and the Aβ peptide
    Storey, E
    Cappai, R
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 1999, 25 (02) : 81 - 97
  • [36] The amyloid peptide and its precursor in Alzheimer's disease
    Octave, JN
    REVIEWS IN THE NEUROSCIENCES, 1995, 6 (04) : 287 - 316
  • [37] Alzheimer's disease: a dysfunction of the amyloid precursor protein
    Neve, RL
    McPhie, DL
    Chen, YH
    BRAIN RESEARCH, 2000, 886 (1-2) : 54 - 66
  • [38] Amyloid Precursor Protein Processing and Alzheimer's Disease
    O'Brien, Richard J.
    Wong, Philip C.
    ANNUAL REVIEW OF NEUROSCIENCE, VOL 34, 2011, 34 : 185 - 204
  • [39] Non-Amyloid Approaches to Disease Modification for Alzheimer’s Disease: An EU/US CTAD Task Force Report
    Serge Gauthier
    P. S. Aisen
    J. Cummings
    M. J. Detke
    F. M. Longo
    R. Raman
    M. Sabbagh
    L. Schneider
    R. Tanzi
    P. Tariot
    M. Weiner
    J. Touchon
    B. Vellas
    The Journal of Prevention of Alzheimer's Disease, 2020, 7 : 152 - 157
  • [40] Cerebral ischemia and Alzheimer's disease: The expression of amyloid-β and apolipoprotein E in human hippocampus
    Qi, Ji-Ping
    Wu, He
    Yang, Yi
    Wang, Dan-dan
    Chen, Yan-xi
    Gu, Yun-he
    Liu, Tao
    JOURNAL OF ALZHEIMERS DISEASE, 2007, 12 (04) : 335 - 341